On the other hand, a team lead by Fu et al. [37] found that TFAP2B was overexpressed in lung adenocarcinoma, which is consistent with the present analysis performed with the TIMER, but not with the GEPIA database. Here, TFAP2B is linked to lung adenocarcinoma.